← FDA Drug Approvals (Drugs@FDA)

RANOLAZINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2019-06-04

Drug application

FDA Application #

ANDA211829

Application type

Abbreviated New Drug Application (Generic)

Brand name

RANOLAZINE

Generic name

RANOLAZINE

Active ingredients

RANOLAZINE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

SCIEGEN PHARMS

Manufacturer

Radha Pharmaceuticals, Inc

First approval

2019-06-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown